Discontinued neuropathic pain therapy between 2009–2015

Sofinicline: a novel nicotinic acetylcholine receptor agonist in the treatment of attention-deficit/hyperactivity disorder

(2014) Carl Fleisher et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Designing innovative therapies for neuropathic pain: preclinical and early clinical development challenges

(2014) A Höke et al.   JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM

Challenges in developing novel therapies for peripheral neuropathies: a summary of The Foundation for Peripheral Neuropathy Scientific Symposium 2012

(2013) Ahmet Höke et al.   JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM

A randomized, double-blind, placebo-controlled trial of a chemokine receptor 2 (CCR2) antagonist in posttraumatic neuralgia

(2013) Jarkko Kalliomäki et al.   PAIN

Neuropathic pain in the general population: A systematic review of epidemiological studies

(2013) O. van Hecke et al.   PAIN

Neuropathic Pain and Pharmacological Treatment

(2013) Joost L. M. Jongen et al.   Pain Practice

The effects of a novel metabotropic glutamate receptor 5 antagonist (AZD2066) on transient lower oesophageal sphincter relaxations and reflux episodes in healthy volunteers

(2012) W. O. Rohof et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

The Rho kinase inhibitor SAR407899 potently inhibits endothelin-1-induced constriction of renal resistance arteries

(2012) Olaf Grisk et al.   JOURNAL OF HYPERTENSION

Erectile properties of the Rho-kinase inhibitor SAR407899 in diabetic animals and human isolated corpora cavernosa

(2012) Fabio Guagnini et al.   Journal of Translational Medicine

Safety and efficacy of esreboxetine in patients with fibromyalgia: An 8-week, multicenter, randomized, double-blind, placebo-controlled study

(2010) Lesley M. Arnold et al.   CLINICAL THERAPEUTICS

Biological, clinical, and ethical advances of placebo effects

(2010) Damien G Finniss et al.   LANCET

Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment

(2010) Ralf Baron et al.   LANCET NEUROLOGY

Anti-TNFα domain antibody construct CEP-37247

(2010) Robert D. Gay et al.   mAbs

Allosteric modulators of NR2B-containing NMDA receptors: molecular mechanisms and therapeutic potential

(2009) Laetitia Mony et al.   BRITISH JOURNAL OF PHARMACOLOGY

The vanilloid receptor TRPV1: Role in cardiovascular and gastrointestinal protection

(2009) Jun Peng et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Evaluation of COX-1/COX-2 selectivity and potency of a new class of COX-2 inhibitors

(2008) James Gierse et al.   EUROPEAN JOURNAL OF PHARMACOLOGY